12-O-Tetradecanoylphorbol-13-Acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

This study has been completed.

Study NCT00004058 Information provided by National Cancer Institute (NCI)

First Received: December 10, 1999 Last Updated: January 31, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given